ClinicalTrials.gov
public full text
Public Domain
A Humanitarian Device Exemption Treatment Protocol of TheraSphere For Treatment of Unresectable Hepatocellular Carcinoma
To provide Therasphere treatment for patients diagnosed with unresectable liver cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial#1089004
- EVLP to Evaluate the Eligibility for Transplantation of DCD-Lungs#854751
- A Randomized Phase II Trial of Cemiplimab Plus OSE2101 ( TEDOPI®) as Maintenance Therapy in ctDNA Positive NSCL. The Cemited Study.#200216
- Procurement of diagnostic equipment for primary care and health care facilities (for ophthalmology and ENT) — Primary Health Care Quality Improvement Program (Kyrgyz Republic)#606996
- Procurement of Biomedical Equipment for Healthcare Facilities in Selected Four Districts on Priority Basis — Khyber Pakhtunkhwa Human Capital Investment Project (Pakistan)#656652
Record · ID 995514
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive